Current Assets Veränderung Datum
Agios Pharmaceuticals USD 833.83M 129.48M 2023-12
ALKERMES USD 1.46B 67.43M 2023-09
Alterity Therapeutics Limited AUD 27.05M 6.16M 2023-06
Amgen USD 30.33B 18.14B 2023-12
Baxter International USD 9.6B 2.43B 2023-12
Biogen USD 6.86B 1.59B 2023-12
Bluebird Bio USD 247.08M 40.9M 2023-09
Bristol-Myers Squibb USD 27.63B 442M 2023-09
Cara Therapeutics USD 100.6M 24.13M 2023-09
Eisai JPY 659.27B 19.2B 2023-09
Eli Lilly USD 23.01B 1.68B 2023-09
Esperion Therapeutics USD 218.23M 13.9M 2023-09
Exelixis USD 1.44B 147.16M 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
GlaxoSmithKline GBP 21.24B 1.89B 2023-09
Grifols EUR 5.02B 210.6M 2023-09
Halozyme Therapeutics USD 746.42M 132.58M 2023-12
Incyte USD 4.65B 242.74M 2023-12
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
Ironwood Pharmaceuticals USD 233.29M 20.32M 2023-12
Merck USD 31.95B 1.98B 2023-09
Nektar Therapeutics USD 399.02M 42.03M 2023-09
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
Pfizer USD 74.01B 665M 2023-09
Roche Holding CHF 30.98B 2.84B 2023-06
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Takeda JPY 2.46T 9.95B 2023-09
Teva Pharmaceutical Industries USD 11.42B 663M 2023-09
Xencor USD 623.16M 51.98M 2023-12



Nektar Therapeutics Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.